BIFIDOLAB patented Bifidobacterium BGN4, was isolated from the intestines of healthy breast-fed infants. It has been registered by FDA NDI and GRAS in the United States, and the strain is safe. At the same time, a number of clinical studies have shown that Bifidobacterium BGN4 can significantly improve and prevent health problems such as dermatitis and eczema, irritable bowel syndrome, ulcerative enteritis and colitis.
Bifidobacterium longum BORI
BIFIDOLAB patented Bifidobacterium longum BORI, was isolated from the intestines of healthy breast-fed infants. This strain has been notificated by US FDA as NDI and GRAS ingredient, and safety has been proved. At the same time, Bifidobacterium longum BORI can effectively inhibit rotavirus, the inhibition rate is as high as 99%, and has been patented by the United States, Japan and South Korea.
Intake of sufficient Fructo-oligosaccharide can effectively help relieve constipation, cooperate with probiotics, and improve intestinal microecological balance.